Second malignancies after autologous hematopoietic cell transplantation in children-Reference-Cited by-同舟云学术

Second malignancies after autologous hematopoietic cell transplantation in children

Published:2012-09-10 Issue:3 Volume:48 Page:363-368
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Danner-Koptik K E,Majhail N S,Brazauskas R,Wang Z,Buchbinder D,Cahn J-Y,Dilley K J,Frangoul H A,Gross T G,Hale G A,Hayashi R J,Hijiya N,Kamble R T,Lazarus H M,Marks D I,Reddy V,Savani B N,Warwick A B,Wingard J R,Wood W A,Sorror M L,Jacobsohn D A

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2012166.pdf

Reference25 articles.

1. Matthay KK . Intensification of therapy using hematopoietic stem-cell support for high-risk neuroblastoma. Pediatr Transplant 1999; 3 (Suppl 1): 72–77.

2. Kletzel M, Katzenstein HM, Haut PR, Yu AL, Morgan E, Reynolds M et al. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: results of the Chicago Pilot II Study. J Clin Oncol 2002; 20: 2284–2292.

3. Stram DO, Matthay KK, O’Leary M, Reynolds CP, Haase GM, Atkinson JB et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children’s Cancer Group studies. J Clin Oncol 1996; 14: 2417–2426.

4. Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 2006; 7: 813–820.

5. Lieskovsky YE, Donaldson SS, Torres MA, Wong RM, Amylon MD, Link MP et al. High-dose therapy and autologous hematopoietic stem-cell transplantation for recurrent or refractory pediatric Hodgkin’s disease: results and prognostic indices. J Clin Oncol 2004; 22: 4532–4540.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry;Blood Advances;2024-07-31

2. International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update;Transplantation and Cellular Therapy;2024-04

3. International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update;Bone Marrow Transplantation;2024-02-27

4. Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant;BMC Cancer;2023-12-20

5. Tandem High-dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors;Cancer Research and Treatment;2023-11-24